Guidelines for point-of-care testing: Improving patient outcomes

Research output: Contribution to journalArticle

87 Citations (Scopus)

Abstract

Whole-blood biosensors and point-of-care testing created a unique paradigm in medical diagnostics in the 1980s, when liver and heart transplant centers, as well as operating rooms and other critical care areas implemented whole- blood analysis to provide rapid test results in 2 to 5 minutes. Rising expectations, patient-focused hospitals, and managed care intensify the need for immediate decisions at the point of care. The guidelines promote consensus priorities, multidisciplinary teamwork, fiscal coordination, and collaborative practice during this phase of rapid change. Four primary principles and accompanying guideline objectives are optimization (patient outcomes, medical linkages, integrated diagnostic synthesis, therapeutic turnaround time, test clusters, and critical limits), hybridization (strategic modalities, economic effectiveness, and testing → monitoring), quality (quality improvement, clinical performance, risk reduction and academics and accreditation), and consistency (results communication and error minimization, and reference intervals and standardization). Whole- blood analysis and point-of-care testing help facilitate temporal optimization, optimize diagnostic-therapeutic processes, and improve patient outcomes in critical care.

Original languageEnglish (US)
JournalAmerican Journal of Clinical Pathology
Volume104
Issue number4 SUPPL. 1
StatePublished - 1995

Fingerprint

Guidelines
Point-of-Care Systems
Patient-Centered Care
Accreditation
Managed Care Programs
Biosensing Techniques
Operating Rooms
Risk Reduction Behavior
Critical Care
Quality Improvement
Consensus
Communication
Economics
Transplants
Liver
Therapeutics
Point-of-Care Testing
Critical Care Outcomes

Keywords

  • Critical care profile
  • Critical limit
  • Hybrid laboratory
  • Medical efficacy
  • Patient monitoring
  • Pseudohyponatremia

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Guidelines for point-of-care testing : Improving patient outcomes. / Kost, Gerald J.

In: American Journal of Clinical Pathology, Vol. 104, No. 4 SUPPL. 1, 1995.

Research output: Contribution to journalArticle

@article{d4ed475c244d4f6da512aadda9443e0a,
title = "Guidelines for point-of-care testing: Improving patient outcomes",
abstract = "Whole-blood biosensors and point-of-care testing created a unique paradigm in medical diagnostics in the 1980s, when liver and heart transplant centers, as well as operating rooms and other critical care areas implemented whole- blood analysis to provide rapid test results in 2 to 5 minutes. Rising expectations, patient-focused hospitals, and managed care intensify the need for immediate decisions at the point of care. The guidelines promote consensus priorities, multidisciplinary teamwork, fiscal coordination, and collaborative practice during this phase of rapid change. Four primary principles and accompanying guideline objectives are optimization (patient outcomes, medical linkages, integrated diagnostic synthesis, therapeutic turnaround time, test clusters, and critical limits), hybridization (strategic modalities, economic effectiveness, and testing → monitoring), quality (quality improvement, clinical performance, risk reduction and academics and accreditation), and consistency (results communication and error minimization, and reference intervals and standardization). Whole- blood analysis and point-of-care testing help facilitate temporal optimization, optimize diagnostic-therapeutic processes, and improve patient outcomes in critical care.",
keywords = "Critical care profile, Critical limit, Hybrid laboratory, Medical efficacy, Patient monitoring, Pseudohyponatremia",
author = "Kost, {Gerald J}",
year = "1995",
language = "English (US)",
volume = "104",
journal = "American Journal of Clinical Pathology",
issn = "0002-9173",
publisher = "American Society of Clinical Pathologists",
number = "4 SUPPL. 1",

}

TY - JOUR

T1 - Guidelines for point-of-care testing

T2 - Improving patient outcomes

AU - Kost, Gerald J

PY - 1995

Y1 - 1995

N2 - Whole-blood biosensors and point-of-care testing created a unique paradigm in medical diagnostics in the 1980s, when liver and heart transplant centers, as well as operating rooms and other critical care areas implemented whole- blood analysis to provide rapid test results in 2 to 5 minutes. Rising expectations, patient-focused hospitals, and managed care intensify the need for immediate decisions at the point of care. The guidelines promote consensus priorities, multidisciplinary teamwork, fiscal coordination, and collaborative practice during this phase of rapid change. Four primary principles and accompanying guideline objectives are optimization (patient outcomes, medical linkages, integrated diagnostic synthesis, therapeutic turnaround time, test clusters, and critical limits), hybridization (strategic modalities, economic effectiveness, and testing → monitoring), quality (quality improvement, clinical performance, risk reduction and academics and accreditation), and consistency (results communication and error minimization, and reference intervals and standardization). Whole- blood analysis and point-of-care testing help facilitate temporal optimization, optimize diagnostic-therapeutic processes, and improve patient outcomes in critical care.

AB - Whole-blood biosensors and point-of-care testing created a unique paradigm in medical diagnostics in the 1980s, when liver and heart transplant centers, as well as operating rooms and other critical care areas implemented whole- blood analysis to provide rapid test results in 2 to 5 minutes. Rising expectations, patient-focused hospitals, and managed care intensify the need for immediate decisions at the point of care. The guidelines promote consensus priorities, multidisciplinary teamwork, fiscal coordination, and collaborative practice during this phase of rapid change. Four primary principles and accompanying guideline objectives are optimization (patient outcomes, medical linkages, integrated diagnostic synthesis, therapeutic turnaround time, test clusters, and critical limits), hybridization (strategic modalities, economic effectiveness, and testing → monitoring), quality (quality improvement, clinical performance, risk reduction and academics and accreditation), and consistency (results communication and error minimization, and reference intervals and standardization). Whole- blood analysis and point-of-care testing help facilitate temporal optimization, optimize diagnostic-therapeutic processes, and improve patient outcomes in critical care.

KW - Critical care profile

KW - Critical limit

KW - Hybrid laboratory

KW - Medical efficacy

KW - Patient monitoring

KW - Pseudohyponatremia

UR - http://www.scopus.com/inward/record.url?scp=0028840244&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028840244&partnerID=8YFLogxK

M3 - Article

C2 - 7484942

AN - SCOPUS:0028840244

VL - 104

JO - American Journal of Clinical Pathology

JF - American Journal of Clinical Pathology

SN - 0002-9173

IS - 4 SUPPL. 1

ER -